GreenMedinfo | 20 June 2022
Most enzymes fall into two categories. Digestive enzymes helps break down food while systemic enzymes, taken away from food, work to fight against unwanted proteins and harmful cells, like cancer cells. Systemic enzymes work to support the body’s normal inflammatory process.
Fibrin is an insoluble protein that the body uses in wound healing and repair. Fibrin can accumulate in the body and present as scar tissue. Pulmonary fibrosis is an accumulation of fibrin in lung tissue.
Serrapeptase, also known as serratiopeptidase or serralysin, is a systemic enzyme, specifically it is a proteolytic enzyme. Serrapeptase was first derived from a species of bacteria found in the intestine of the silkworm. The bacteria, Serratia mercesans E1, produces serrapeptase to help breakdown the silkworm coccoon to free the silk moth.
A 2020 review study summarized that serrapeptase has immense applications in therapeutic areas which have been validated by several in vitro, in vivo, and clinical studies. “These applications are attributable to its versatile properties including anti-inflammatory, anti-biofilm, analgesic, anti-edemic, and fibrinolytic effects.” (source)
- the management of pain and inflammation
- carpal tunnel syndrome
- rheumatoid arthritis
- wound debridement
- post-traumatic swelling
- ruptured ligaments
- chronic swelling and injuries
- breast engorgement (source)
- autoimmune diseases
- fibrocystic breast disease
- uterine fibroids
- pulmonary fibrosis (source)
- kidney fibrosis
- arterial plaque (scar tissue in arteries)
- blood clots
Serrapeptase for Joint Swelling
Serrapeptase is effective in reducing post-operative joint swelling in comparison to other therapies such as applying ice. (source)
It has been known to decrease the natural fluid viscosity in joints after physical impacts encouraging a quicker recovery to regain mobility and comfort which is especially beneficial to those who live an active lifestyle.
Serrapeptase Dissolves Blood Clots, Dead Tissue, Biofilms
Anticoagulants and antiplatelet drugs are used for managing cardiovascular diseases but they are unable to dissolve an existing blood clot. Serrapeptase dissolves a fibrin clot within a blood vessel. (source)
Serrapeptase for Acute or Chronic Ear, Nose and Throat Conditions
The Journal of International Medical Research published the results of a study evaluating the efficacy and tolerability of serrapeptase using a double-blind, placebo-controlled study of 193 subjects suffering from acute or chronic ear, nose or throat disorders. Patients treated with serrapeptase reported significant symptom regression within 3 – 4 days. It was concluded that serrapeptase “has anti-inflammatory, anti-oedemic and fibrinolytic activity and acts rapidly on localized inflammation.” (source)
COVID-19 and Chronic Respiratory Conditions
A 2021 study, Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19 showed, “Proteolytic enzymes can be useful in the treatment of nosocomial, viral, and resistant infections, especially in pediatric and geriatric age groups due to its relative safety, less tolerance and resistance and its synergic effects.” (source).
Physicians have observed many COVID-19 cases with heart problems, kidney problems, and the presence of blood clots. Serrapeptase helps patients with chronic airway disease by reducing coughing and lessening viscosity of sputum. As a natural anticoagulant it interferes with platelet aggregation and the blood coagulation cascade. Serrapeptase has an anti-inflammatory impact on the tissue inflammation that contributes to the blood clot formation. (source)
Serrapeptase is useful in treating chronic respiratory diseases, sinusitis, ear, nose and throat diseases, relieves coughs, and could be useful in COVID-19 cases, delaying pulmonary complications. (source)
Many COVID-19 cases show heart problems, blood clots and kidney problems. Proteolytic enzymes such nattokinase and serrapeptase are natural anticoagulants. When taken away from food, these enzymes fight the coagulation cascade by breaking down fibrin clots and inhibiting platelet aggregation. (source)
Normal aging reduces the level of proteolytic enzymes in the body. Supplementation offers an affordable way to balance the body’s level of proteolytic enzymes to assist with the breakdown of fibrin and other unwanted protein and cells.
Serrapeptase is a well-tolerated, inexpensive and natural option for many conditions. It can be taken at higher doses when required.
Dosage recommendations depend on product choice and health condition. Remember systemic enzymes are taken on an empty stomach — one hour before a meal or at least two hours after.
Serrapeptase – Long, safe history
Serrapeptase has a long, safe history of use in traditional medicine throughout Asia and Europe for over 30 years and now has been extensively studied in North America for its therapeutic benefits.
Hundreds of serrapeptase users’ case studies, research and dosage information can be found online in a free ebook, The Miracle Enzyme is Serrapeptase: The 2nd gift from silkworms, by Robert Redfern.